We are live on ! Find out more
SLDB icon

Solid Biosciences
SLDB

55 hedge funds and large institutions have $466M invested in Solid Biosciences in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 2

356% more capital invested

Capital invested by funds: $102M → $466M (+$364M)

267% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 6

56% more call options, than puts

Call options by funds: $248K | Put options by funds: $159K

41% more funds holding

Funds holding: 39 → 55 (+16)

10.21% more ownership

Funds ownership: 82.45% → 92.66% (+10%)

Holders
55
Holders Change
+16
Holders Change %
+41.03%
% of All Funds
0.79%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
22
Increased
24
Reduced
2
Closed
6
Calls
$248K
Puts
$159K
Net Calls
+$89K
Net Calls Change
+$47K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$31.9M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$23.8M
3
DM
Deerfield Management
New York
+$21.2M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$16.9M
5
AG
Artal Group
Luxembourg
+$14.9M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$8.71M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.08M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$901K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$28K
5
A
AJOVista
Massachusetts
-$23.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$1.15M +$805K +86,004 New
State Street
27
State Street
Massachusetts
$976K +$269K +28,700 +64%
JP Morgan Chase
28
JP Morgan Chase
New York
$936K +$656K +70,144 +52,740%
Renaissance Technologies
29
Renaissance Technologies
New York
$916K +$287K +30,700 +81%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$873K +$146K +15,590 +31%
BCM
31
Bridgeway Capital Management
Texas
$680K – – –
Man Group
32
Man Group
United Kingdom
$652K +$458K +48,922 New
Citigroup
33
Citigroup
New York
$636K +$446K +47,712 New
Northern Trust
34
Northern Trust
Illinois
$558K +$128K +13,651 +48%
MTIM
35
Marathon Trading Investment Management
Pennsylvania
$497K +$349K +37,300 New
Citadel Advisors
36
Citadel Advisors
Florida
$459K +$322K +34,425 New
Bank of America
37
Bank of America
North Carolina
$404K +$247K +26,402 +667%
American Century Companies
38
American Century Companies
Missouri
$329K +$231K +24,704 New
ECM
39
ExodusPoint Capital Management
New York
$321K +$225K +24,085 New
Balyasny Asset Management
40
Balyasny Asset Management
Illinois
$313K +$220K +23,525 New
Morgan Stanley
41
Morgan Stanley
New York
$296K +$128K +13,719 +162%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$193K +$136K +14,500 New
UBS Group
43
UBS Group
Switzerland
$190K +$95.7K +10,225 +254%
RJFSA
44
Raymond James Financial Services Advisors
Florida
$177K +$124K +13,259 New
Charles Schwab
45
Charles Schwab
California
$137K +$96.2K +10,276 New
Barclays
46
Barclays
United Kingdom
$58.8K – – –
Lazard Asset Management
47
Lazard Asset Management
New York
$21K +$15.2K +1,629 New
HFS
48
Hantz Financial Services
Michigan
$13K +$3.13K +334 +50%
TWC
49
TD Waterhouse Canada
Ontario, Canada
$2.95K +$1.68K +180 New
Wells Fargo
50
Wells Fargo
California
$2.18K +$833 +89 +119%
1
2
3

SLDB Hedge Fund Activity: Q1 2024 in Review

55 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q1 2024, worth a combined $466M — up 356% from $102M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SLDB positions and 6 closed out — a net gain of 16 holders — while 24 added to existing stakes and 2 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $31.9M. The largest seller was Camber Capital Management, exiting entirely with an estimated $8.71M sold.

  • 55 institutional investors held Solid Biosciences (SLDB) as of Q1 2024, up from 39 in Q4 2023.
  • Funds reported $466M of Solid Biosciences stock for Q1 2024, up 356% quarter-over-quarter.
  • 22 funds opened new Solid Biosciences positions in Q1 2024 and 6 closed out, a net change of +16 holders.
  • The largest Solid Biosciences buyer in Q1 2024 was Perceptive Advisors, an estimated $31.9M added.
  • The largest Solid Biosciences seller in Q1 2024 was Camber Capital Management, an estimated $8.71M sold.

Based on aggregated 13F filings for Q1 2024.